Search

everythinglearnresearchcommunity

for

Search:↓

Hormones might affect the skin condition hidradenitis suppurativa, but their exact role is unclear.

Treatments for PCOS aim to reduce androgen levels and improve insulin sensitivity to lower cardiometabolic risk.

Transgender women can develop feminine traits and improve their quality of life through hormone therapy and surgery, but results vary and access to surgery can be limited.

Measuring certain hormones can help predict metabolic risk in women with PCOS.

Low-dose bisphenol A increases prostate size in rats by affecting certain enzymes.

Men and women get COVID-19 at similar rates, but men tend to get sicker and have a higher risk of dying, while women usually have stronger immune responses and vaccine reactions.

Hormones affect skin aging and fat distribution, and treatments can help, but only minoxidil is proven for female hair loss.

Hormone levels in hair change during pregnancy, with progesterone increasing significantly compared to non-pregnant women.

Melasma's causes include genetics, sun exposure, hormones, and oxidative stress, and understanding these can help create better treatments.

Quercetin may help improve symptoms of polycystic ovary syndrome.

Skin problems like acne and excess hair in PCOS are common and linked to being overweight.

Interval training is better for heart and metabolic health in reproductive-aged females than regular moderate exercise.

Women with PCOS have a higher risk of heart disease.

Ethnic Indian women with PCOS often have early symptoms, delayed diagnosis, and need better information and support for treatment and lifestyle management.

Hormonal therapies can improve skin issues by adjusting hormone levels, with future advancements promising better results.

Women have a higher DHT/testosterone ratio than men, possibly due to gut bacteria activity.

Effective treatments for excessive body hair in women include drugs that block androgens, sometimes combined with oral contraceptives.

Sebum is essential for skin health but can cause acne if unbalanced.

Hormonal imbalances can cause acne, excess hair growth, and hair loss in women, needing combined medical and emotional care.

PCOS is a common hormonal disorder in women that causes various symptoms and health risks, requiring personalized treatment.

5-alpha reductase inhibitors and spironolactone don't increase gynecological tumor risk, glucagon-like-peptide-1 receptor agonists may increase alopecia risk, sanitary pads can cause dermatitis, early hidradenitis suppurativa intervention is crucial for Hispanic patients, community education boosts skin cancer awareness, metformin may improve skin cancer survival, LNG-IUDs can increase acne risk, machine learning accurately detects basal cell carcinoma, JAK-inhibitors may raise miscarriage risk, inclusive skincare ads affect those with darker skin, and CCCA in Black women might involve autoimmunity.

Non-surgical treatments can significantly reduce keloids in children, with combination therapies being safer and more effective.

Hormonal therapies effectively treat acne and improve quality of life.

Lifestyle changes like a healthy diet, exercise, and proper sleep can help manage PCOD.

Metformin lowers prolactin in women without PCOS but not in those with PCOS, where it reduces other hormones instead.

5-Alpha Reductase Inhibitors are effective for male hair loss and some skin conditions, but their effectiveness in women and safety concerns require careful use.

Polycystic Ovary Syndrome (PCOS) is a common but often undiagnosed disorder in women that can cause irregular periods, infertility, and other symptoms, and can be managed with lifestyle changes, medication, and sometimes surgery.

Women with Polycystic Ovary Syndrome (PCOS) have lower levels of a substance called DIAPH1 in their blood, which is linked to changes in sugar metabolism and insulin resistance.

Women with newly diagnosed PCOS may have worse gum health than those treated for PCOS.

Female pattern hair loss does not significantly affect sexual dysfunction.